好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

In vitro Microglia Cell Line and Human Mesenchymal Stem Cells Viability IS Inhibited by Hydrogen Gas
Autoimmune Neurology
P1 - Poster Session 1 (5:30 PM-6:30 PM)
15-093

To investigate the effect of hydrogen gas on viability of human mesenchymal stem cell (hMSCs) and human microglial cell line CHME5

Oxidative stress was recognized as one of major cause of various diseases such as neurodegenerative diseases, aging, and cancer. Hydrogen gas, a powerful reducer, has been demonstrated the ability to diminish oxidative stress and reduce reactive oxygen species (ROS)

Cell viability will be studied with the Cell Titer-Blue assay (Promega Corporation, ). HMSCs or CHME5 cells were seeded in 96-well plates at 5x103/well in DMEM with 10% FCS in 200 mL volume. Half plates were cultured under normal condition (5% CO2 ambient atmosphere) while another half plated were supplemented with 3.2% hydrogen gas, 5% CO2, balanced air. After 24 h,48h and 72h, the cells were incubated with the cell titer blue reagent for 2 h and then immediately analyzed with SYNERGY 4H reader using an absorbance of 560 nm excitation/590 nm emission reference wavelength (Biotek, Winooski, VT).

After 24h, normal cell fluorescent reading was 41809 ± 660.87AU while MSCs in hydrogen is 8031.0 ± 1274.1 AU ((p<0.0001); after 48h, normal cell fluorescent reading was 22197 ± 448.37 AU while MSCs in hydrogen was 3337.0± 2402.6 AU (p<0.0001);  After 72h, normal cell fluorescent reading is 36116 ± 2981.2 AU while MSCs in hydrogen is 1461.2 ± 704.53 AU (p=0.0079). Similar data were obtained with CHME5.

These data suggest that hydrogen gas have obvious toxicity effect on cell viability of hMSCs and CHME5 cells, which may raise some questions about the clinical application of hydrogen gas. The specific mechanism is still under investigation

Authors/Disclosures

PRESENTER
No disclosure on file
Nizar Souayah, MD, FAAN (NJMS) Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.